SEC Comment Letter for Streamex Corp. (STEX) (CIK 0001530766) (STEX) — May 26, 2015
Streamex Corp. (STEX) (CIK 0001530766)
Date: May 26, 2015 · CIK: 0001530766 · Accession: 0000000000-15-027986
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-204335
Letter
May 2 2, 2015 Via E -mail Kenneth Londoner Executive Chairman BioSig Technologies, Inc. 8441 Wayzata Blvd., Suite 240 Minneapolis, Minnesota 55426
Re: BioSig Technologies , Inc. Registration Statement on Form S-1 Filed May 20 , 2015 File No. 333-204335
Dear Mr. Londoner :
This is to advise you that we have not reviewed and will not review your registration statement .
We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Act of 193 3 and all applicable Securities Act rules require. Since the company and its management are in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made.
In the event you request acceleration of the effective date of the pending regist ration statement , please provide a written statement from the company acknowledging that:
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action wit h respect to the filing;
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Kenneth Londoner BioSig Technologies, Inc. May 22 , 2015 Page 2
Please refer to Rules 460 and 461 regarding requests for acceleration . We will consider a written request for acceleration of the effective date of the registration statement as confirmation of the fact that those requesting acceleration are aware of their respective responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed public offering of the registered securities .
Please contact Mary Beth Breslin at (202) 551 -3625 with any questions.
Sincerely,
/s/ Mary Beth Breslin for
Show Raw Text
May 2 2, 2015 Via E -mail Kenneth Londoner Executive Chairman BioSig Technologies, Inc. 8441 Wayzata Blvd., Suite 240 Minneapolis, Minnesota 55426 Re: BioSig Technologies , Inc. Registration Statement on Form S-1 Filed May 20 , 2015 File No. 333-204335 Dear Mr. Londoner : This is to advise you that we have not reviewed and will not review your registration statement . We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Act of 193 3 and all applicable Securities Act rules require. Since the company and its management are in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made. In the event you request acceleration of the effective date of the pending regist ration statement , please provide a written statement from the company acknowledging that: should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action wit h respect to the filing; the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Kenneth Londoner BioSig Technologies, Inc. May 22 , 2015 Page 2 Please refer to Rules 460 and 461 regarding requests for acceleration . We will consider a written request for acceleration of the effective date of the registration statement as confirmation of the fact that those requesting acceleration are aware of their respective responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed public offering of the registered securities . Please contact Mary Beth Breslin at (202) 551 -3625 with any questions. Sincerely, /s/ Mary Beth Breslin for Amanda Ravitz Assistant Director cc (via e -mail): Rick A. Werner , Esq.